June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Visual outcome predictors in acute optic neuritis
Author Affiliations & Notes
  • Sangah Kim
    Ophthalmology, Yonsei University College of Medicine, Seoul, Korea (the Republic of)
  • Samin Hong
    Ophthalmology, Yonsei University College of Medicine, Seoul, Korea (the Republic of)
  • Chan Yun Kim
    Ophthalmology, Yonsei University College of Medicine, Seoul, Korea (the Republic of)
  • Gong Je Seong
    Ophthalmology, Yonsei University College of Medicine, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships Sangah Kim, None; Samin Hong, None; Chan Yun Kim, None; Gong Je Seong, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5534. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Sangah Kim, Samin Hong, Chan Yun Kim, Gong Je Seong; Visual outcome predictors in acute optic neuritis. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5534.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To find the visual outcome predictors in patients who received intravenous steroid pulse therapy (ISPT) due to acute optic neuritis (AON).

 
Methods
 

A retrospective, observational, clinical study. A total of 33 AON patients received ISPT (methylprednisolone, 250 mg, four times a day, 3 days) and had follow-up checkups for at least 3 months after the therapy were included in this study. Patients were divided into two groups, those who finally recovered their vision over LogMAR 0.3 (Group 1, n=25) vs. those who didn’t (Group 2, n=8). We evaluated the demographics and clinical characteristics and tried to determine which factors had affected the visual outcome.

 
Results
 

The presence of a relative afferent pupillary defect (RAPD) and a pattern of visual field (VF) defect at presentation, and the degree of visual loss at the 3 month and 1 year after treatment were associated to the final visual outcome. While, age, gender, bilaterality, moving pain, headaches, and the degree of vision and color sense loss were not related to the final visual outcome. The presence of disc swelling and retinal nerve fiber layer (RNFL) defect, the abnormal responses on visual evoked potential (VEP), the abnormal level of erythrocyte sedimentation rate (ESR) and/or C-reactive protein (CRP) were also not associated with the final visual outcome.

 
Conclusions
 

At presentation, the RAPD and VF defect excluding visual loss were associated with the final visual outcome in AON patients who had received ISPT. Regarding vision, the visual acuity at 3 months and 1 year after treatment were associated with the final visual outcome.

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×